Country Profile

Namibia

Namibia is a growing market for Indian pharmaceuticals — $35.2M in FY 2025–26. Medicines accounts for 75% of shipments, with vaccines contributing $8.68M.

🇳🇦 $35.2M · 1.2× growth since FY2015 · 1.4% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$35.2M
Exports FY2025–26 DGCIS
1.2×
Growth FY2015→2026
1.4%
CAGR FY2015→2026
75%
Medicines Share
4
Product Categories Supplied
Namibia is a growing market for Indian pharmaceuticals — $35.2M in FY 2025–26. Medicines accounts for 75% of shipments, with vaccines contributing $8.68M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $26.4M (74.9%) Vaccines $8.68M (24.7%) Surgical & Hospital Supplies $148K (0.4%) Medicine Ingredients $13K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Namibia in the RBI overseas direct investment dataset (2011–2026).